Latest return on equity
Acrivon Therapeutics Return on equity
Direct answer
Acrivon Therapeutics's return on equity is -64.63%.
The verified market snapshot reports -64.63%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 9, 2026.
Get free Acrivon Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -64.63%
Explore related company data
View Acrivon Therapeutics's market capitalizationView Acrivon Therapeutics's price-to-book ratioView Acrivon Therapeutics's 52-week price rangeView Acrivon Therapeutics's profit marginView Acrivon Therapeutics's debt-to-equity ratioView all Acrivon Therapeutics key metricsReturn to Acrivon Therapeutics profile